Oppenheimer & Co’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
1CP
NRW
KIM
Oppenheimer & Co's BME Position: Q2 2026 in Review
Oppenheimer & Co increased its BlackRock Health Sciences Trust (BME) stake by 1.1% in Q2 2026, buying an estimated $2.98K and bringing the position to 6,849 shares worth $294K. The position accounts for ﹤0.01% of the portfolio, ranked #1486.
Oppenheimer & Co first reported a position in BME in Q2 2021 and has held it in 18 quarters since. 79 funds tracked by Wall St. Rank hold BME as of Q2 2026.
- Oppenheimer & Co held 6,849 shares of BlackRock Health Sciences Trust worth $294K as of Q2 2026.
- Oppenheimer & Co bought 75 BlackRock Health Sciences Trust shares in Q2 2026, an estimated $2.98K.
- BlackRock Health Sciences Trust made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1486 holding.
- Oppenheimer & Co first reported a position in BlackRock Health Sciences Trust in Q2 2021 and has held it in 18 quarters since.
- 79 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2026.
Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.